These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10374204)

  • 1. [HIV-protease inhibitors: pros and cons].
    Briones C; Soriano V
    Med Clin (Barc); 1999 May; 112(18):702-5. PubMed ID: 10374204
    [No Abstract]   [Full Text] [Related]  

  • 2. More clinical data on protease inhibitors.
    Smart T
    GMHC Treat Issues; 1995 Oct; 9(10):4-7. PubMed ID: 11362917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common HIV drug-drug interactions.
    O'Brien LW
    AIDS Read; 1999; 9(2):104-9. PubMed ID: 12728892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TB drugs interact adversely with protease inhibitors.
    AIDS Alert; 1996 Oct; 11(10):117-8. PubMed ID: 11363854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Protease inhibitors are effective only on HIV-infected cells].
    Fortschr Med; 1996 May; 114(15):12. PubMed ID: 8767934
    [No Abstract]   [Full Text] [Related]  

  • 6. [An important point of attach in AIDS treatment. HIV protease inhibitors: state of the art].
    Clement B
    Pharm Unserer Zeit; 2001; 30(3):208-11. PubMed ID: 11400668
    [No Abstract]   [Full Text] [Related]  

  • 7. Proteases and protease inhibitors.
    Van Noorden CJ
    Acta Histochem; 1997 Aug; 99(3):245-7. PubMed ID: 9381907
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anti-HIV compounds].
    Kiso Y; Kisanuki S
    Nihon Rinsho; 1993 Sep; 51 Suppl():235-40. PubMed ID: 8271390
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of a novel screen for protease inhibitors.
    Gillim L; Gusella GL; Vargas J; Marras D; Klotman ME; Cara A
    Clin Diagn Lab Immunol; 2001 Mar; 8(2):437-40. PubMed ID: 11238235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protease inhibitors: patient education critical.
    James JS
    AIDS Treat News; 1996 Apr; (no 244):1-3. PubMed ID: 11363303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular modeling in the battle against AIDS. Drugs design in the development of substrate-like HIV protease inhibitors].
    Klebe G
    Pharm Unserer Zeit; 2001; 30(3):194-201. PubMed ID: 11400666
    [No Abstract]   [Full Text] [Related]  

  • 12. Saquinavir thwarts resistance.
    AIDS Alert; 1995 Oct; 10(10):123. PubMed ID: 11362782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Protease inhibitors of the human immunodeficiency virus].
    Roca B; Simón E
    Med Clin (Barc); 1998 Mar; 110(10):375-7. PubMed ID: 9567280
    [No Abstract]   [Full Text] [Related]  

  • 14. [New therapeutic possibilities in AIDS].
    Heinzl S
    Med Monatsschr Pharm; 1996 May; 19(5):121. PubMed ID: 8684307
    [No Abstract]   [Full Text] [Related]  

  • 15. Protease inhibitors: no knockout blow, but could be the best punch yet.
    AIDS Alert; 1996 Apr; 11(4):37-9. PubMed ID: 11363400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AmFAR extols FDA on rapid approval of two protease inhibitors.
    AIDS Patient Care STDS; 1996 Jun; 10(3):193-4. PubMed ID: 11361645
    [No Abstract]   [Full Text] [Related]  

  • 17. [New ammunition in the battle against AIDS].
    Agosto M
    Sidahora; 1997; ():25-6. PubMed ID: 11364803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease inhibitor consensus statement.
    AIDS Treat News; 1995 Mar; (no 219):7. PubMed ID: 11362333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [After 3 years no resistance development. Protease inhibitor with staying power].
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():56-7. PubMed ID: 12043076
    [No Abstract]   [Full Text] [Related]  

  • 20. Aim at 95% adherence to PIs.
    AIDS Read; 2000 Sep; 10(9):525. PubMed ID: 11019444
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.